OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG., N-803 (NAI), OncoTICE® 2-8 x 108 vermehrungsfähige Einheiten Pulver zur Herstellung einer Suspension zur intravesikalen Instillation
QUILT-2.005
Phase 2 small_molecule active
Quick answer
OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG., N-803 (NAI), OncoTICE® 2-8 x 108 vermehrungsfähige Einheiten Pulver zur Herstellung einer Suspension zur intravesikalen Instillation for Non-Muscle Invasive Bladder Cancer is a Phase 2 program (small_molecule) at Immunitybio Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immunitybio Ireland Limited
- Indication
- Non-Muscle Invasive Bladder Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active